IE000KD0BZ68
IE000KD0BZ68
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Loading chart...
Holdings & Portfolio Structure
Holdings as of 08/11/2026Detailed breakdown of ETF components
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | Healthcare | Diagnostics & Research | 51,55 Mrd. € | 5.75% | - | -2028.91 | 13.09% | 31.59 | 21.34 | -247.20 | 555.23 | 0.18% | FY Cur +26.17% (22) Q Cur +19.45% (20) FY Next +20.65% (22) Q Next +5.85% (18) | FY Cur +5.05% (16) Q Cur +58.50% (15) FY Next +86.32% (16) Q Next +60.98% (14) | |
| 2 | Illumina, Inc. | Healthcare | Diagnostics & Research | 37,49 Mrd. € | 4.80% | 51.90 | 45.46 | 89.04% | 14.80 | 9.35 | 35.77 | 52.66 | 1.90% | FY Cur +6.48% (19) Q Cur +6.34% (17) FY Next +6.46% (19) Q Next +5.84% (16) | FY Cur +10.69% (21) Q Cur +1.31% (19) FY Next +14.20% (21) Q Next +13.15% (18) | |
| 3 | Agilent Technologies, Inc. | Healthcare | Diagnostics & Research | 42,91 Mrd. € | 4.76% | 33.64 | 25.24 | 56.34% | 6.53 | 6.52 | 23.94 | 45.34 | 2.21% | FY Cur +7.95% (20) Q Cur +6.87% (16) FY Next +6.42% (21) Q Next -3.19% (8) | FY Cur +10.94% (21) Q Cur +8.54% (18) FY Next +8.94% (22) Q Next -13.08% (11) | |
| 4 | Danaher Corporation | Healthcare | Diagnostics & Research | 137,91 Mrd. € | 4.44% | 38.77 | 23.64 | 52.97% | 2.94 | 6.15 | 21.97 | 35.73 | 2.80% | FY Cur +7.26% (23) Q Cur +8.37% (19) FY Next +8.09% (23) Q Next +15.68% (17) | FY Cur +9.09% (25) Q Cur +1.39% (20) FY Next +9.29% (25) Q Next +34.80% (20) | |
| 5 | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 115,31 Mrd. € | 4.27% | 29.71 | 25.23 | 9.77% | 6.38 | 10.26 | 23.86 | 49.17 | 2.03% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | FY Cur -11.12% (16) Q Cur -115.38% (13) FY Next +23.62% (16) Q Next +721.48% (14) | |
| 6 | LONZA N | Healthcare | Diagnostics & Research | 42,95 Mrd. € | 4.11% | 37.92 | 25.94 | 51.12% | 4.92 | 5.82 | 18.00 | - | -3.92% | FY Cur +9.02% (23) Q Cur - (0) FY Next +11.47% (23) Q Next - (0) | FY Cur +23.28% (17) Q Cur - FY Next +19.03% (18) Q Next - | |
| 7 | Insmed Incorporated | Healthcare | Biotechnology | 19,61 Mrd. € | 4.10% | - | 127.76 | 97.65% | 28.99 | 19.31 | -27.07 | - | -2.60% | FY Cur +197.18% (22) Q Cur +250.76% (20) FY Next +59.72% (21) Q Next +12.87% (19) | FY Cur +75.47% (18) Q Cur +78.64% (17) FY Next +150.00% (18) Q Next +14.14% (17) | |
| 8 | Guardant Health, Inc. | Healthcare | Diagnostics & Research | 20,06 Mrd. € | 3.94% | - | -405.82 | - | - | 19.00 | -53.09 | 844.66 | 0.12% | FY Cur +38.24% (25) Q Cur +32.20% (21) FY Next +35.29% (25) Q Next +5.32% (20) | FY Cur +19.43% (21) Q Cur +19.79% (17) FY Next +71.86% (19) Q Next +11.31% (17) | |
| 9 | ROCHE PS | Healthcare | Drug Manufacturers - General | 306,41 Mrd. € | 3.76% | 23.34 | 16.33 | 90.72% | 8.72 | 4.53 | 12.88 | 27.63 | 3.62% | FY Cur +2.26% (13) Q Cur +5.49% (3) FY Next +4.60% (15) Q Next +4.42% (2) | FY Cur +4.67% (16) Q Cur - FY Next +7.55% (16) Q Next - | |
| 10 | Moderna, Inc. | Healthcare | Biotechnology | 80,17 Mrd. € | 3.75% | - | -50.70 | 19.04% | 13.28 | 40.32 | -34.08 | 300.18 | 0.33% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | FY Cur -15.53% (21) Q Cur -149.18% (15) FY Next +43.00% (20) Q Next -37.19% (14) | |
| 11 | GSK PLC | Healthcare | Drug Manufacturers - General | 81,82 Mrd. € | 3.62% | 14.86 | - | 106.50% | 4.11 | 51.23 | 158.60 | 488.42 | 0.20% | FY Cur +3.83% (22) Q Cur +3.56% (8) FY Next +4.68% (20) Q Next +1.29% (8) | FY Cur - Q Cur - FY Next - Q Next - | |
| 12 | argenx SE | Healthcare | Biotechnology | 46,31 Mrd. € | 3.37% | 31.19 | 23.76 | 0.56% | 153.25 | 9.76 | 790.35 | 68.11 | 1.47% | FY Cur +48.20% (4) Q Cur +43.13% (2) FY Next +21.64% (4) Q Next +8.94% (2) | FY Cur -4.56% (4) Q Cur -288.71% (2) FY Next +85.91% (3) Q Next +189.72% (1) | |
| 13 | WUXI BIO | Healthcare | Biotechnology | 25,21 Mrd. € | 3.16% | 40.80 | 29.06 | 5.00% | 3.93 | 9.38 | 24.08 | 91.62 | 1.09% | FY Cur +17.96% (23) Q Cur - (0) FY Next +19.57% (25) Q Next - (0) | FY Cur +16.32% (14) Q Cur - FY Next +19.78% (15) Q Next - | |
| 14 | Medpace Holdings, Inc. | Healthcare | Diagnostics & Research | 15,25 Mrd. € | 2.67% | 35.94 | 31.69 | 33.22% | 39.37 | 6.14 | 26.94 | 33.47 | 2.99% | FY Cur +12.72% (13) Q Cur +8.27% (11) FY Next +6.33% (13) Q Next +0.89% (11) | FY Cur +15.94% (10) Q Cur +15.57% (8) FY Next +9.03% (10) Q Next +5.05% (8) | |
| 15 | Revvity, Inc. | Healthcare | Diagnostics & Research | 15,35 Mrd. € | 2.23% | 73.77 | 26.18 | 46.23% | 2.38 | 5.91 | 22.03 | 28.44 | 3.52% | FY Cur -0.12% (16) Q Cur -0.60% (15) FY Next +5.40% (16) Q Next +9.33% (14) | FY Cur +5.77% (17) Q Cur +9.86% (16) FY Next +10.03% (17) Q Next +24.51% (15) | |
| 16 | INNOVENT BIO | Healthcare | Biotechnology | 18,37 Mrd. € | 2.03% | 121.91 | 42.92 | 11.20% | 6.63 | 10.29 | 79.50 | 32.76 | 3.05% | FY Cur +42.30% (28) Q Cur - (0) FY Next +23.96% (30) Q Next - (0) | FY Cur +43.06% (13) Q Cur - FY Next +52.47% (13) Q Next - | |
| 17 | SANDOZ GROUP N | Healthcare | Drug Manufacturers - Specialty & Generic | 32,42 Mrd. € | 2.00% | 59.59 | 15.22 | 68.92% | 4.16 | 2.58 | 21.75 | 22.04 | 4.54% | FY Cur +9.16% (14) Q Cur +7.15% (2) FY Next +5.31% (14) Q Next +11.53% (1) | FY Cur +12.34% (15) Q Cur - FY Next +12.03% (15) Q Next - | |
| 18 | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 22,75 Mrd. € | 1.77% | 24.52 | 19.19 | 81.07% | 3.38 | 2.21 | 13.96 | 28.03 | 3.57% | FY Cur +8.86% (15) Q Cur +8.31% (12) FY Next +4.58% (15) Q Next -1.17% (12) | FY Cur +13.66% (16) Q Cur +10.39% (14) FY Next +7.48% (16) Q Next -6.56% (14) | |
| 19 | Qiagen N.V. | Healthcare | Diagnostics & Research | 8,36 Mrd. € | 1.75% | 23.04 | 17.37 | 49.25% | 2.79 | 4.46 | 13.70 | 25.13 | 3.98% | FY Cur +2.16% (17) Q Cur +0.38% (9) FY Next +5.06% (17) Q Next +7.17% (9) | FY Cur +2.28% (13) Q Cur -3.35% (9) FY Next +7.32% (13) Q Next +5.41% (9) | |
| 20 | Bio-Techne Corp | Healthcare | Biotechnology | 10,14 Mrd. € | 1.70% | 62.47 | 31.33 | 13.71% | 5.37 | 9.35 | 34.08 | 49.48 | 2.02% | FY Cur +4.35% (12) Q Cur +1.97% (8) FY Next +10.04% (9) Q Next +5.33% (7) | FY Cur +4.48% (11) Q Cur +6.92% (7) FY Next +14.69% (9) Q Next +7.19% (6) | |
| 21 | BeOne Medicines Ltd. | Healthcare | Biotechnology | 35,99 Mrd. € | 1.69% | 63.41 | 34.58 | 39.61% | 7.74 | 6.58 | 34.30 | 45.88 | 2.18% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | FY Cur +202.03% (17) Q Cur +72.26% (12) FY Next +34.16% (17) Q Next -17.26% (12) | |
| 22 | Madrigal Pharmaceuticals, Inc. | Healthcare | Biotechnology | 9,73 Mrd. € | 1.49% | - | 49.01 | 66.40% | 20.80 | 8.49 | -32.79 | - | -0.74% | FY Cur +59.37% (18) Q Cur +41.14% (17) FY Next +39.35% (17) Q Next +9.89% (17) | FY Cur +48.98% (4) Q Cur +78.05% (4) FY Next +248.25% (4) Q Next +61.15% (4) | |
| 23 | Twist Bioscience Corporation | Healthcare | Biotechnology | 9,45 Mrd. € | 1.38% | - | -399.45 | 24.36% | 22.47 | 24.53 | -82.20 | - | -0.61% | FY Cur +21.18% (12) Q Cur +24.77% (11) FY Next +20.16% (11) Q Next +2.34% (8) | FY Cur +54.63% (4) Q Cur +67.26% (3) FY Next +58.32% (4) Q Next +6.33% (3) | |
| 24 | Krystal Biotech, Inc. | Healthcare | Biotechnology | 8,76 Mrd. € | 1.33% | 41.56 | 35.78 | 0.65% | 7.22 | 22.28 | 44.41 | 64.68 | 1.55% | FY Cur +29.71% (9) Q Cur +31.99% (9) FY Next +28.43% (10) Q Next +7.22% (9) | FY Cur +13.10% (11) Q Cur -25.59% (10) FY Next +19.79% (11) Q Next +6.75% (10) | |
| 25 | Arrowhead Pharmaceuticals, Inc. | Healthcare | Biotechnology | 7,89 Mrd. € | 1.30% | - | -12.73 | 295.98% | 19.03 | 13.20 | -41.68 | - | -0.55% | FY Cur -44.33% (15) Q Cur -77.18% (14) FY Next -27.60% (15) Q Next -21.82% (6) | FY Cur -35300.40% (14) Q Cur -752.98% (14) FY Next -39.29% (14) Q Next +11.01% (7) |
Results: 117
Weight 5.75%
Market Cap €51.55B
P/E -
Fwd P/E -2028.9
Weight 4.8%
Market Cap €37.49B
P/E 51.9
Fwd P/E 45.5
Weight 4.76%
Market Cap €42.91B
P/E 33.6
Fwd P/E 25.2
Weight 4.44%
Market Cap €137.91B
P/E 38.8
Fwd P/E 23.6
Weight 4.27%
Market Cap €115.31B
P/E 29.7
Fwd P/E 25.2
Weight 4.11%
Market Cap €42.95B
P/E 37.9
Fwd P/E 25.9
Weight 4.1%
Market Cap €19.61B
P/E -
Fwd P/E 127.8
Weight 3.94%
Market Cap €20.06B
P/E -
Fwd P/E -405.8
Weight 3.76%
Market Cap €306.41B
P/E 23.3
Fwd P/E 16.3
Weight 3.75%
Market Cap €80.17B
P/E -
Fwd P/E -50.7
Weight 3.37%
Market Cap €46.31B
P/E 31.2
Fwd P/E 23.8
Weight 3.16%
Market Cap €25.21B
P/E 40.8
Fwd P/E 29.1
Weight 2.67%
Market Cap €15.25B
P/E 35.9
Fwd P/E 31.7
Weight 2.23%
Market Cap €15.35B
P/E 73.8
Fwd P/E 26.2
Weight 2.03%
Market Cap €18.37B
P/E 121.9
Fwd P/E 42.9
Weight 2%
Market Cap €32.42B
P/E 59.6
Fwd P/E 15.2
Weight 1.77%
Market Cap €22.75B
P/E 24.5
Fwd P/E 19.2
Weight 1.75%
Market Cap €8.36B
P/E 23.0
Fwd P/E 17.4
Weight 1.7%
Market Cap €10.14B
P/E 62.5
Fwd P/E 31.3
Weight 1.69%
Market Cap €35.99B
P/E 63.4
Fwd P/E 34.6
Weight 1.49%
Market Cap €9.73B
P/E -
Fwd P/E 49.0
Weight 1.38%
Market Cap €9.45B
P/E -
Fwd P/E -399.4
Weight 1.33%
Market Cap €8.76B
P/E 41.6
Fwd P/E 35.8
Weight 1.3%
Market Cap €7.89B
P/E -
Fwd P/E -12.7
Results 1 - 25 of 117
Per page:
Page 1 / 5